Liraglutide in adolescents with simple obesity and gastrointestinal comorbidities: treatment experience
BACKGROUND: Liraglutide was approved for treatment of obesity in children and adolescents since 12 years. Due to gastrointestinal (GI) side effects not all patients reach maximal dose; this can affect the efficacy of obesity treatment.AIM: To study efficacy and tolerability of liraglutide in adolesc...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2023-07-01
|
Series: | Ожирение и метаболизм |
Subjects: | |
Online Access: | https://www.omet-endojournals.ru/jour/article/view/12922 |